Abstract
Selenium (Se) is an essential nutritional factor that affects the development and expression of cell-mediated immune responses directed toward malignant cells. These studies have shown that dietary (2 ppm for 8 wk) or in in vitro (1×10−7 M) supplementation with Se (as sodium selenite) results in a significant enhancement of the proliferative responses of spleen lymphocytes from C57B1/6J mice in response to stimulation with mitogen or antigen. Se deficiency (0.02 ppm for 8 wk) had the opposite effect. The alterations in the ability of the cells to proliferate, which occurred in the absence of changes in the endogenous levels of interleukin-2 (II2) or interleukin 1, were apparently related to the ability of Se to alter the kinetics of expression of high-affinity Il2 receptors on the surface of activated lymphocytes. This resulted in an enhanced or delayed clonal expansion of the cells, and in an increased or decreased frequency of cytotoxic cells within a given cell population. The changes in tumor cytotoxicity were paralleled by changes in the amounts of lymphotoxin produced by the activated cells. Dietary Se modulations had a comparable effect on macrophage-mediated tumor cytodestruction. The results also suggested that Se exerts its effect 8–24 h after stimulation, and that it most likely affects processes in the cytoplasmic and/or nuclear compartments of activated lymphocytes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. Kiremidjian-Schumacher and G. Stotzky,Environ. Res. 42, 277–303 (1987).
D. Medina and D. G. Morrison,Pathol. Immunopathol. Rev. 7, 187–198 (1988).
P. A. Talcott, J. H. Exon, and L. D. Koller,Cancer Lett. 23, 313–322 (1984).
H. C. Meeker, M. L. Eskew, W. Schenchenzuber, R. W. Scholz, and A. Zarkower,J. Leuk. Biol. 38, 451–458 (1985).
H. Stotter and M. T. Lotze,Cancer Cells 2, 44–55 (1990).
T. R. Tritton and J. A. Hickman,Cancer Cells 2, 95–105 (1990).
H. Warner, C. Hardt, B. T. Rouse, M. Rollinghoff, P. Scheurich, and K. Pfizenmaier,J. Exp. Med. 155, 1876–1881 (1982).
H. Weiss, J. Imboden, K. Hardy, B. Manger, C. Terhorst, and J. Stobo,Ann. Rev. Immunol. 4, 593–619 (1986).
W. L. Farrar and F. W. Ruscetti,J. Immunol. 136, 1266–1275 (1986).
E. Pelosi-Testa, P. Samoggia, G. Giannella, E. Montesoro, T. Caravita, G. Salvo, A. Camagna, G. Isacchi, U. Testa, and C. Peschle,Immunology 64, 273–279 (1988).
K. A. Smith,Science 240, 1169–1176 (1988).
M. S. Meltzer and J. J. Oppenheim,J. Immunol. 118, 77–82 (1977).
L. Kiremidjian-Schumacher, M. Roy, H. I. Wishe, M. W. Cohen, and G. Stotzky,Proc. Soc. Exp. Biol. Med. 193, 136–142 (1989).
M. Roy, L. Kiremidjian-Schumacher, H. I. Wishe, M. W. Cohen, and G. Stotzky,Proc. Soc. Exp. Biol. Med. 193, 143–148 (1989).
M. A. Beilstein, P. D. Whanger, and I. Wong,Selenium in Biology and Medicine, Part A, G. F. Combs, J. E. Spallholz, O. H. Levander and J. E. Oldfield, eds., Van Nostrand Reinold Co., New York, 1987, pp. 197–212.
D. E. Kern, L. B. Lachmann, and P. D. Greenberg,J. Immunol. 139, 2880–2887 (1987).
D. A. Cantrell and K. A. Smith,Science 224, 1312–1316 (1984).
T. A. Waldman,Science 232, 727–732 (1988).
R. J. Robb,Proc. Natl. Acad. Sci. USA 83, 3992–3996 (1986).
D. A. Cantrell and K. A. Smith,J. Exp. Med. 158, 1895–1911 (1983).
R. J. Robb and W. C. Green,J. Exp. Med. 165, 1201–1206 (1987).
R. J. Robb, P. C. Mayer, and R. Garlick,J. Immunol. Meth. 81, 15–30 (1985).
T. P. Koestler, W. J. Johnson, D. Rieman, B. J. Dalton, R. G. Greig, and G. Poste,Cancer Res. 47, 2807–2808 (1987).
L. Kiremidjian-Schumacher, M. Roy, H. I. Wishe, M. W. Cohen, and G. Stotzky,J. Nutrit. Immunol. 1, 65–79 (1992).
M. Baccarini, R. Schwinzer, and M-L. Lohmann-Matthes,J. Immunol 142, 118–125 (1989).
M. M. Hatakeyama, S. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, M. Miyasaka, and T. Taniguchi,Science 244, 551–556 (1989).
E. Bohnlein, D. W. Ballard, H. Bogerd, N. J. Peffer, J. W. Lowenthal, and W. C. Green,J. Biol. Chem. 264, 8475–8478 (1989).
W. J. Leonard, M. Kronke, N. J. Peffer, J. M. Deeper, and W. Green,Proc. Natl. Acad. Sci. USA 82, 6281–6285 (1985).
W. C. Willet, B. V. Polk, J. S. Morris, M. J. Sampler, S. Pressil, B. Rosner and J. Taylor,Lancet. 2, 130–134 (1987).
D. Medina,J. Am. Coll. Toxicol. 5, 21–26 (1986).
R. A. Miller and O. Stutman,Eur. J. Immunol. 11, 751–756 (1981).
R. Miller,J. Immunol. 132, 63–68 (1984).
J. Bubenick, B. Cinader, M. Indrova, S. W. Kohn, and C.-T. Chou,Immunol. Letters 16, 113–119 (1987).
J. J. Provst, D. S. Kittur, M. A. Buchholz, and A. A. Nordin,J. Immunol. 141, 4209–4215 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kiremidjian-Schumacher, L., Roy, M., Wishe, H.I. et al. Regulation of cellular immune responses by selenium. Biol Trace Elem Res 33, 23–35 (1992). https://doi.org/10.1007/BF02783989
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02783989